Bionpharma divalproex sodium tablets recalled for foreign tablets
Bionpharma Inc. is recalling 500 mg divalproex sodium delayed-release tablets because the bottles have foreign tablets or capsules in them. No injuries have been reported. The recall covers one lot sold nationwide.
From the FDA notice · Read the official notice ↗
What to do
- Talk to your pharmacist or prescriber before stopping this medicine.
- Check the bottle for lot 704C003, expiration date 12/31/2028, and NDC 69452-435-30.
- The notice doesn't say how to get a refund or replacement; contact Bionpharma Inc. or the pharmacy where you bought it.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500 Tablets bottles, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, Made in India, NDC 69452-435-30.
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Units affected
- N/A
- Illnesses reported
- None reported
- Manufactured in
- 400 Alexander Park Ste 2-4b, N/A, Princeton, NJ, United States
- Classification
- Class II
- Recall number
- D-0742-2026
In the FDA's words
- Description
- Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500 Tablets bottles, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, Made in India, NDC 69452-435-30. Presence of Foreign Tablets/Capsules Lot# 704C003, Exp. 12/31/2028 Distribution: US Nationwide. Affected quantity: N/A
- Hazard
- Presence of Foreign Tablets/Capsules
More from Bionpharma
- Bionpharma doxylamine/pyridoxine recalled for foreign tablets
ModerateFDASep 9, 2026